Evropska unija - slovenščina - EMA (European Medicines Agency)

janssen-cilag international n.v. - talquetamab - multiple myeloma - antineoplastična sredstva - talvey is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least 3 prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti cd38 antibody and have demonstrated disease progression on the last therapy.

Evropska unija - slovenščina - EMA (European Medicines Agency)

abbvie deutschland gmbh & co. kg - epcoritamab - lymphoma, large b-cell, diffuse - antineoplastična sredstva - tepkinly as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b-cell lymphoma (dlbcl) after two or more lines of systemic therapy.

Evropska unija - slovenščina - EMA (European Medicines Agency)

janssen-cilag international n.v. - teclistamab - multiple myeloma - antineoplastična sredstva - tecvayli is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.

Evropska unija - slovenščina - EMA (European Medicines Agency)

immunocore ireland limited - tebentafusp - uveal neoplasms - antineoplastična sredstva - kimmtrak is indicated as monotherapy for the treatment of human leukocyte antigen (hla)-a*02:01-positive adult patients with unresectable or metastatic uveal melanoma.

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

koncentrat za raztopino za infundiranje - daclizumab

Evropska unija - slovenščina - EMA (European Medicines Agency)

roche registration gmbh  - glofitamab - lymphoma, large b-cell, diffuse - antineoplastična sredstva - columvi as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl), after two or more lines of systemic therapy.

Evropska unija - slovenščina - EMA (European Medicines Agency)

roche registration gmbh - mosunetuzumab - limfom, folikularni - antineoplastic agents, monoclonal antibodies - lunsumio as monotherapy is indicated for the treatment of adult patients with relapsed or refractory follicular lymphoma (fl) who have received at least two prior systemic therapies.

Evropska unija - slovenščina - EMA (European Medicines Agency)

astellas pharma europe bv - takrolimus - zavrnitev presadka - imunosupresivi - preprečevanje zavrnitve presadka pri prejemnikih alogenskega presadka ledvic ali jeter. zdravljenje zavrnitve alogenskega presadka, odpornega na zdravljenje z drugimi imunosupresivnimi zdravili pri odraslih bolnikih.

Evropska unija - slovenščina - EMA (European Medicines Agency)

astellas pharma europe b.v. - takrolimus - zavrnitev presadka - imunosupresivi - preprečevanje zavrnitve presadka pri prejemnikih alogenskega presadka pri odraslih in pediatričnih, ledvičnih, jetrnih ali srčnih. zdravljenje allograft zavrnitev odporne na zdravljenje z drugimi imunosupresivnimi zdravili pri odraslih in pediatričnih bolnikih.

Evropska unija - slovenščina - EMA (European Medicines Agency)

teva b.v. - takrolimus monohidrat - liver transplantation; kidney transplantation - imunosupresivi - preprečevanje zavrnitve presadka pri prejemnikih alogenskega presadka ledvic ali jeter. zdravljenje zavrnitve alogenskega presadka, odpornega na zdravljenje z drugimi imunosupresivnimi zdravili pri odraslih bolnikih.